Summit Therapeutics Inc. today announced it has entered into a clinical trial collaboration with GSK plc ("GSK", LSE/NYSE: GSK) to evaluate ivonescimab, a novel, investigational PD-1 / VEGF bispecific ...
Dr Liam O’Brien from the University of Liverpool has secured a £2.1 million EPSRC Open Fellowship to develop advanced magnetic nanoparticle tracers for next-generation medical imaging. The ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback